A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaLucy Gately, Carmen Balañá, Anthony Dowling et al.|Journal of Neuro-Oncology|2023Cited by 5
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaLucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2024Cited by 3
A phase (Ph) 0/Ia study of brigimadlin concentration in brain tissue and a non-randomized, open-label, dose escalation study of brigimadlin in combination with radiotherapy (RT) in patients (pts) with newly diagnosed glioblastoma (GBM).Jann N. Sarkaria, Evanthia Galanis, Maciej M. Mrugała et al.|Journal of Clinical Oncology|2024Cited by 3
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)Lucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2024Cited by 2
CTNI-54. A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMALucy Gately, Carmen Balañá, Carlos Mesía et al.|Neuro-Oncology|2023Cited by 0